EACH: Evaluating Avelumab in Combination With Cetuximab in Head and Neck Cancer

NCT03494322 · clinicaltrials.gov ↗

PHASE2

Phase

ACTIVE_NOT_RECRUITING

Status

130

Enrollment

OTHER

Sponsor class

Conditions

Head and Neck Cancer
Squamous Cell Carcinoma

Interventions

DRUG: Avelumab
DRUG: Cetuximab

Sponsor

University College, London

Collaborators

[object Object]